1. Abdelaal, M., le Roux, C.W., Docherty, N.G. (2017). Morbidity and mortality associated with obesity. Ann Trans Med., 5(7), 161-173.
doi:10.21037/atm.2017.03.107.
2. Abdolali, B., Neda, R., Ardeshir, Z., Yaser, K. (2012). Effect of 12 weeks of aerobic training on visfatin levels in obese women. Euro. J. Exp. Bio., 2(6), 2293-2296.
3. Achari, A.E., Jain, S.K. (2017). Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction. Int J Mol Sci., 18(6), 1321.
doi:10.3390/ijms18061321.
4. Achten, J., Jeukendrup, A. (2004). Optimizing fat oxidation through exercise and diet. Nutrition, 20, 716-727.
5. Acquarone, E., Monacelli, F., Borghi, R., Nencioni, A., Odetti, P. (2019). Resistin:
A reappraisal. Mech ageing Dev., 178, 46-63. doi:10.1016/j.mad.2019.01.004.
6. Ahima, R.S., Lazar, M.A. (2008). Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol., 22(5), 1023-1031.
7. Ahmad, N., Adam, S. I. M., Nawi, A. M., Hassan, M. R., Ghazi, H. F. (2016). Abdominal Obesity Indicators: Waist Circumference or Waist-to-hip Ratio in Malaysian Adults Population. Int J Prev Med, 7, 82. doi:10.4103/2008-7802.183654.
8. Akil. L., Ahmad, H.A. (2011). Relationships between obesity and cardiovascular diseases in four southern states and Colorado. J of Health Care for the Poor and Underserved, 22(4A), 61-72. doi:10.1353/hpu.2011.0166.
9. Alan, M., Gurlek, B., Yilmaz, A., Aksit, M., Aslanipour, B., Gulhan, I. i wsp.
(2019). Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol, 35(3), 220-223.
doi:10.1080/09513590.2018.1512967.
10. Alberti, K.G., Zimmet, P., Shaw, J. (2006). The metabolic syndrom - a new worldwide definition. Lancet., 366, 1059-1062. doi:10.1016/S0140-6736(05)67402-8.
11. Al-Daghri, N.M., Alkharfy, K.M., Rahman, S., Amer, O. E., Vinodson, B., Sabico, S. (2014). Irisin as a predictor of glucose metabolism in children: sexually dimorphic effects. Eur J Clin Invest., 44, 119-124. doi:10.1111/eci.12196.
12. Amato, M.C., Giordano, C., Galia, M., Criscimanna, A., Vitabile, S., Midiri, M. i wsp.
(2010). Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care, 33, 920-922. doi:10.2337/dc09-1825.
13. Anastasilakis, A.D., Polyzos, S.A., Saridakis, Z.G., Kynigopoulos, G., Skouvaklidou, E.C., Molyvas, D. i wsp. (2014). Circulating Irisin in Healthy, Young Individuals: Day-Night Rhythm, Effects of Food Intake and Exercise, and Associations With Gender, Physical Activity, Diet, and Body Composition. J Clin Endocrinol Metab, 99(9), 3247-3255. doi:10.1210/jc.2014-1367.
14. Åstrand I., 1960. Aerobic work capacity in men and women with special reference to age. Acta Physiol. Scand., 49(169), 1-92.
15. Augustyniak, A., Skrzydlewska, E. (2004). Zdolności antyoksydacyjne w starzejącym się organizmie. Postępy Hig. Med. Dośw., 58, 194-201.
16. Balducci, S., Zanuso, S., Nicolucci, A., Fernando, F., Cavallo, S., Cardelli, P. i wsp.
(2010). Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab and Cardiovasc Dis, 20(8), 608-617.
doi:10.1016/j.numecd.2009.04.015.
17. Barness, L.A., Opitz, J.M., Gilbert-Barness, E. (2007). Obesity: Genetic, molecular, and environmental aspects. Am J Med Genet Part A, 143A(24), 3016-3034.
18. Bartosz, G. (2003). Druga twarz tlenu: wolne rodniki w przyrodzie. Warszawa. PWN.
19. Baszczuk, A., Kopczyński, Z. (2014). Hyperhomocysteinemia in patients with cardiovascular disease. Postepy Hig Med Dosw, 68, 579-589.
20. Bays, H., Blonde, L., Rosenson, R. (2006). Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients? Expert review of cardiovascular therapy, 4(6), 871-895. doi:10.1586/14779072.4.6.871.
21. Becic, T., Studenik, C., Hoffmann, G. (2018). Exercise Increases Adiponectin and Reduces Leptin Levels in Prediabetic and Diabetic Individuals: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Med Sci (Basel), 6(4), 97.
doi:10.3390/medsci6040097.
22. Benedict, C., Shostak, A., Lange, T., Brooks, S.J., Schiöth, H.B., Schultes, B., i wsp. (2012). Diurnal rhythm of circulating nicotinamide phosphoribosyltransferase (Nampt/visfatin/PBEF): impact of sleep loss and relation to glucose metabolism. J Clin Endocrinol Metab, 97(2), 218–222. doi:10.1210/jc.2011-2241.
23. Bergman, R.N., Stefanovski, D., Buchanan, T.A., Sumner, A.E., Reynolds, J.C., Sebring, N.G. i wsp. (2011). A better index of body adiposity. Obesity (Silver Spring, Md.), 19(5), 1083-1089. doi:10.1038/oby.2011.38.
24. Besnier, F., Lenclume, V., Gérardin, P., Fianu, A., Martinez, J., Naty, N. i wsp.
(2015) Individualized Exercise Training at Maximal Fat Oxidation Combined with Fruit and Vegetable-Rich Diet in Overweight or Obese Women: The LIPOXmax-Réunion Randomized Controlled Trial. PloS one, 10(11), 0139246.
doi:10.1371/journal.pone.0139246.
25. Biernat, E., Stupnicki, R., Gajewski, A.K. (2007). Międzynarodowy Kwestionariusz Aktywności Fizycznej (IPAQ) – wersja polska. Wychowanie Fizyczne i Sport, 51 (1), 47-54.
26. Bijak, M., Ponczek, M.B., Saluk, J., Chabielska, M., Stępniak J., Nowak, P. (2012).
Nadtlenoazotyn – silny biologiczny utleniacz. Wiadomości chemiczne, 66, 7-8.
27. Bird, S.R., Hawley, J.A. (2017). Update on the effects of physical activity on insulin sensitivity in humans. BMJ Open Sport Exer Med, 2(1), 000143. doi:
10.1136/bmjsem-2016-000143.
28. Blüher, S., Mantzoros, C. S. (2009). Leptin in humans: lessons from translational research. Am J Clin Nutr, 89, 991-997.
29. Blus, E., Wojciechowska-Kulik, A., Majewska, E., Baj, Z. (2019). Usefulness of New Indicators of Obesity (BAI and VAI) in Estimation of Weight Reduction. J Am Coll of Nutr, 1-7. doi:10.1080/07315724.2019.1630024
30. Bo, S., Gambino, R., Durazzo, M., Ghione, F., Musso, G., Gentile, L. (2008).
Associations between serum uric acid and adipokines, markers of inflammation, and endothelial dysfunction, J Endocrinol Invest, 31, 499-504.
31. Bo, S., Gambino, R., Pagani, A., Guidi, S., Gentile, L., Cassader, M. i wsp. (2005).
Relationships between human serum resistin, inflammatory markers and insulin resistance. Int. J. Obes., 29, 1315-1320.
32. Bobbert, T., Wegewitz, U., Brechtel, L., Freudenberg, M., Mai, K., Möhlig, M. i wsp.
(2007). Adiponectin oligomers in human serum during acute andchronic exercise:
relation to lipid metabolism and insulin sensitivity. Int J Sports Med., 28, 1-8.
33. Bogdański, P., Iciek, J., Pupek-Musialik D. (2011). Wpływ regularnej aktywności fizycznej na stężenie adiponektyny u otyłych kobiet z zespołem metabolicznym Endokrynol. Otył. Zab. Przem. Mat., 7(4), 213-221.
34. Bohne, M., Abendroth-Smith, J. (2007). Effects of hiking downhill using trekking poles while carrying external loads. Med Sci Sports Exerc, 39(1), 177-183.
35. Bokarewa, M., Nagaev, I., Dahlberg, L., Smith, U., Tarkowski, A. (2005). Resistin, an adipokine with potent proinflammatory properties. J Immunol., 174(9), 5789-5795. doi:10.4049/jimmunol.174.9.5789.
36. Borg, G.A.V. (1982). Psychophysical bases of perceived exertion. Med. Sci Sports Exerc, 14(5), 377-381. doi: 10.1249/00005768-198205000-00012.
37. Boström, P., Wu, J., Jedrychowski, M.P., Korde, A., Ye, L., Lo, J. C. i wsp. (2012).
A PCG-1α – dependent myokine that drives brown-fatlike development of white fat and thermogenesis. Nature, 481, 463-468.
38. Botero, J.P., Prado, W.L., Guerra, R.L.F., Speretta, G.F.F., Leite, R.D., Prestes, J.
i wsp. (2013). Does aerobic exercise intensity affect health-related parameters in overweight women? Clin Physiol Funct Imaging, 34(2), 138-142. doi:10.1111/cpf.12076.
39. Bove, P.F., van der Vliet, A. (2006). Nitric oxide and reactive nitrogen species in airway epithelial signalling and inflammation. Free Radic. Biol. Med., 40, 398-406.
40. Bowman, G.L., Shannon, J., Frei, B., Kaye, J.A., Quinn, J.F. (2010). Uric acid as a CNS antioxidant. J Alzheimer's Dis, 19(4), 1331-1336. doi: 10.3233/JAD-2010-1330.
41. Breyer, M.K., Breyer-Kohansal, R., Funk, G.C., Dornhofer, N., Spruit, M.A., Wouters, E.F. (2010). Nordic walking improves daily physical activities in COPD: a randomised controlled trial. Respir Res, 11(1), 112. doi: 10.1186/1465-9921-11-112.
42. Brończyk-Puzoń, A., Koszowska, A., Bieniek, J. (2018). Podstawowe pomiary antropometryczne i pochodne wskaźniki w poradnictwie dietetycznym – część pierwsza. Piel Zdr Publ., 8(3), 217–222.
43. Bullo, V., Gobbo, S., Vendramin, B., Duregon, F., Cugusi, L., Di Blasio, A. i wsp.
(2018). Nordic Walking Can Be Incorporated in the Exercise Prescription to Increase Aerobic Capacity, Strength, and Quality of Life for Elderly:
A Systematic Review and Meta-Analysis. Rejuvenat. Res., 21, 141-161.
44. Cannon, B., Nedergaard, J. (2004). Brown adipose tissue: function and physiological significance. Physiol. Rev., 84, 277-359.
45. Cao, L., Jiang, Y., Li, Q., Wang, J., Tan, S. (2019). Exercise Training at Maximal Fat Oxidation Intensity for Overweight or Obese Older Women: A Randomized Study. J Sports Sci Med, 18(3), 413-418.
46. Cebula, A., Tyka, A.K., Tyka, A., Pałka, T., Pilch, W., Luty, L. i wsp.
(2020) Physiological response and cardiorespiratory adaptation after a 6-week Nordic Walking training targeted at lipid oxidation in a group of post-menopausal women. PLOS ONE 15(4): 0230917. doi: 10.1371/journal.pone.0230917.
47. Ceylan, H.I, Saygın, Ö., Türkcü, Ü. Ö. (2020) Assessment of acute aerobic exercise in the morning versus evening on asprosin, spexin, lipocalin-2, and insulin level in overweight/obese versus normal weight adult men. Chronobiol Int, 37(8), 1252–
1268.doi: 10.1080/07420528.2020.1792482.
48. Ceylan, H.İ., Saygın, Ö. (2020). An investigation of the relationship between new fasting hormone asprosin, obesity and acute-chronic exercise: current systematic review. Archi Physiol Biochem, 1–12. doi: 10.1080/13813455.2020.1767652.
49. Chang, C.S., Chang, Y.F., Wang, M.W., Chen, C.-Y., Chao, Y.-J., Chang, H.-J.
i wsp. (2013). Inverse relationship between central obesity and osteoporosis in osteoporotic drug naive elderly females: The Tianliao Old People (TOP) Study. J Clin Densitom, 16(2), 204-211. doi: 10.1016/j.jocd.2012.03.008.
50. Chávez-Guevara, I.A., Urquidez-Romero, R., Pérez-León, J.A., González-Rodríguez, E., Moreno-Brito, V., Ramos-Jiménez, A. (2020). Chronic Effect of Fatmax Training on Body Weight, Fat Mass, and Cardiorespiratory Fitness in Obese Subjects: A Meta-Analysis of Randomized Clinical Trials. Int. J. Environ. Res.
Public Health, 17(21), 7888. doi:10.3390/ijerph17217888.
51. Chen, K., Pittman, R.N., Popel, A.S. (2008). Nitric oxide in the vasculature: where does it come from and where does it go? A quantitative perspective. Antioxid Redox Signal., 10, 1185-1198.
52. Chen, L.Y., Zhu, W.H., Chen, Z.W., Dai, H L., Ren, J.J., Chen, J.H. i wsp. (2007).
Relationship between hyperuricemia and metabolic syndrome. J Zhejiang Univ Sci B, 8(8), 593-598. doi: 10.1631/jzus.2007.B0593.
53. Chen, M.P., Chung, F.M., Chang, D.M., Tsai, J.C., Huang, H.F., Shin, S.J. i wsp.
(2006). Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrin Metab, 91(1), 295-299. doi:
10.1210/jc.2005-1475.
54. Choi, K. M., Kim, J. H., Cho, G.J., Baik, S.H., Park, H.S., Kim, S.M. (2007). Effect of exercise training on plasma visfatin and eotaxin levels. European journal of endocrinology, 157(4), 437-442. doi: 10.1530/EJE-07-0127.
55. Choi, Y.K., Kim, M.K., Bae, K.H., Seo, H.A., Jeong, J.Y., Lee, W.K. (2013). Serum irisin levels in New-onset type 2 diabetes. Diabetes Res. Clin. Pract., 100, 96-101.
56. Chudek, J. (2009). Wpływ indywidualnej edukacji chorych z nadciśnieniem tętniczym na poprawę kontroli ciśnienia tętniczego, redukcję masy ciała i zaprzestanie palenia papierosów. Probl. Med. Rodz., 1(26), 63-69.
57. Cinti, S. (2018). Pink Adipocytes. Trends Endocrinol. Metab, 29, 651-666.
58. Cornier, M.A., Dabelea, D., Hernandez, T.L., Lindstrom, R.C., Steig, A.J., Stob, N.R. (2008). The Metabolic Syndrome, Endocr Rev, 29(7), 777-822. doi:
doi.org/10.1210/er.2008-0024.
59. Corrêa, L.H., Heyn, G.S., Magalhaes, K.G. (2019). The Impact of the Adipose Organ Plasticity on Inflammation and Cancer Progression. Cells, 8(7), 662-680. doi:
10.3390/cells8070662.
60. Cugusi, L., Solla, P., Serpe, R., Carzedda, T., Piras, L., Oggianu, M. i wsp. (2015).
Effects of a Nordic Walking program on motor and non-motor symptoms, functional performance and body composition in patients with Parkinson’s disease.
NeuroRehabilitation, 37, 245-254.
61. Dakroub, A., A Nasser, S., Younis, N., Bhagani, H., Al-Dhaheri, Y., Pintus, G. i wsp. (2020). Visfatin: A Possible Role in Cardiovasculo-Metabolic Disorders. Cells, 9(11), 2444. doi: 10.3390/cells9112444.
62. de Leal, V.O., Marfa, D. (2013). Adipokines in obesity. Clin Chim. Acta, 419, 87-94.
63. Dermican, N., Gurel, A., Armutcu, F., Unalacak, M., Aktunc, E., Atmaca, H.
(2008). The evaluation of serum cystatin C, malondialdehyde, and total antioxidant status in patients with metabolic syndrome. Med Sci Monit, 14(2), 97-101.
64. Dill, D.B., Costill D.L. (1974). Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J. Appl. Physiol. 37, 247-248. doi:
10.1152/jappl.1974.37.2.247.
65. Dill, D.B., Costill, D.L. (1974). Calculation of percentage changes in volumes of blood, plasma and cells in dehydration. J Appl Physiol. 37(2), 243-248.
66. Doll, S., Paccaud, F., Bovet, P., Burnier, M., Wietlisbach, V. (2002). Body mass index, abdominal adiposity and blood pressure: consistency of their association across developing and developed countries. Int. J. Obes. Relat. Metab. Disord., 26(1), 48-57.
67. Dong, H., Xu, Y., Zhang, X., Tian, S. (2017). Visceral adiposity index is strongly associated with hyperuricemia independently of metabolic health and obesity phenotypes.
Scientific Reports, 7(1), 8822. doi:10.1038/s41598-017-09455-z.
68. Doyle, S.L., Donhoe, C.L., Lysaght, J., Reynolds, J.V. (2012). Visceral obesity, metabolic syndrome, insulin resistance and cancer. Proc. Nutr. Soc., 71, 181-189.
doi: 10.1017/S002966511100320X.
69. Drygas, W., Bielecki, W., Pająk, A., Piotrowski, W. (2015). Wieloośrodkowe Ogólnopolskie Badanie Stanu Zdrowia Ludności - WOBASZ. Kopeć G, Jankowski P, Pająk A, Drygas W. (red.). Epidemiologia i prewencja chorób układu krążenia.
Medycyna Praktyczna, Kraków, 43-56.
70. Duerrschmid, C., He, Y., Wang C, Li, C, Bournat, J.C., Romere, C. i wsp. (2017).
Asprosin is a centrally acting orexigenic hormone. Nat Med., 23, 1444-1453.
doi: 10.1038/nm.4432.
71. Dumortier, M., Brandou, F., Perez-Martin, A., Fedou, C., Mercier, J., Brun, J.F. (2003).
Low intensity endurance exercise targeted for lipid oxidation improves body composition and insulin sensitivity in patients with the metabolic syndrome. Diabetes Metab, 29(5), 509-518. doi:10.1016/s1262-3636(07)70065-4.
72. Duracková Z. (2010). Some current insights into oxidative stress. Physiol Res, 59(4), 459-469.
73. Dvořáková-Lorenzová, A., Suchánek, P., Havel, P. J., Stávek, P., Karasová, L., Valenta, Z. i wsp. (2006). The decrease in C-reactive protein concentration after diet and physical activity induced weight reduction is associated with changes in plasma
lipids, but not interleukin-6 or adiponectin. Metabolism, 55(3), 359-365. doi:10.1016/j.metabol.2005.09.010.
74. Eglit, T., Lember, M., Ringmets, I., Rajasalu, T. (2013). Gender differences in serum high-molecular-weight adiponectin levels in metabolic syndrome. Eur J Endocrinol, 168(3), 385-391. doi:10.1530/EJE-12-0688.
75. Elshamaa, M.F., Sabry, S.M., El-Sonbaty, M.M., Elghoroury, E.A., Emara, N., Raafat, M. i wsp. (2012). Adiponectin: an adipocyte-derived hormone, and its gene encoding in children with chronic kidney disease. BMC Res Notes., 5, 174. doi: 10.1186/1756-0500-5-174.
76. Esteghamati, A., Morteza, A., Zandieh, A., Jafari, S., Rezaee, M., Nakhjavani, M. i wsp. (2012). The value of visfatin in the prediction of metabolic syndrome: a multi-factorial analysis. J Cardiovasc Res, 5(4), 541-546. doi: 10.1007/s12265-012-9373-8.
77. Evans, A.L., Paggiosi, M.A., Eastell, R., Walsh, J. S. (2015). Bone density, microstructure and strength in obese and normal weight men and women in younger and older adulthood. J Bone Miner Res. 30(5): 920-928, doi: 10.1002/jbmr.2407.
78. Fang, H., Judd, R.L. (2018). Adiponectin regulation and function. Compr Physiol., 8(3), 1031-1063.
79. Feig, D.I., Kang D.-K., Johnson R.J. (2009) Kwas moczowy a ryzyko sercowo-nacyzniowe. N Engl J Med., 359, 1811-1821.
80. Fenster, C.P., Weinsier, R.L., Darley-Usmar, V.M., Patel, R.P. (2002). Obesity, Aerobic Exercise, and Vascular Disease: The Role of Oxidant Stress, Obes Res, 10, 9, 964-968.
81. Ferguson, M.A., White, L.J., McCoy, S., Kim, H.-W., Petty, T., Wilsey, J. (2004).
Plasma adiponectin response to acute exercise in healthy subjects. Eur J Appl Physiol, 91, 324-329.
82. Fernández-Sánchez, A., Madrigal-Santillán, E., Bautista, M., Esquivel-Soto, J., Morales-González, A., Esquivel-Chirino, C. i wsp. (2011). Inflammation, oxidative stress, and obesity. Int. J. Mol. Sci., 12, 3117-3132.
83. Fett, C.A., Fett, W.C.R, Marchini, J.S. (2009). Circuit Weight Training vs Jogging in Metabolic Risk Factors of Overweight/Obese Women. Arq Bras Cardiol, 93(5), 480-486.
84. Figard-Fabre, H., Fabre, N., Leonardi, A., Schena, F. (2010). Physiological and perceptual responses to Nordic walking in obese middle-aged women in comparison with the normal walk. Eur J Appl Physiol., 108(6), 1141-1151. doi:
10.1007/s00421-009-1315-z.
85. Figard-Fabre, H., Fabre, N., Leonardi, A., Schena, F. (2011). Efficacy of Nordic walking in obesity management. Int J Sports Med, 32(6), 407-414. doi: 10.1055/s-0030-1268461.
86. Finaud, J., Lac, G., Filaire, E., (2006). Oxidative stress. Relationship with exercise and training. Sports Med. 36, 327-358.
87. Finkel, T., Holbrook N.J. (2000). Oxidants, oxidative stress and the biology of ageing. Nature, 408, 239-247.
88. Fischer, S., Hanefeld, M., Haffner, S.M., Fusch, C., Schwanebeck, U., Kohler, C. i wsp. (2002). Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass. Acta Diabetol., 39, 105-110.
doi: 10.1007/s005920200027.
89. Foremska-Iciek, J., Hoffman, K., Pupek-Musialik, D. (2009). Ocena osoczowego stężenia wisfatyny u chorych z zespołem metabolicznym i samoistnym ciśnieniem tętniczym. Arterial Hypertension,13(4), 258-265. review. Arch Endocrinol Metab,61(6), 614-622. doi: 10.1590/2359-3997000000316.
92. Frayn, K.N. (1983). Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol Respir Environ Exerc Physiol, 55(2), 628-634. doi:
10.1152/jappl.1983.55.2.628.
93. Friedewald, W.Y., Levy, R.I., Fredrickson, D.S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 18, 499-502.
94. Fritschi, J.O., Brown, W.J., Laukkanen, R., van Uffelen, J.G.Z. (2012). The effects of pole walking on health in adults: A systematic review. Scand J Med Sci Spor., 22(5), 70-78.
95. Fritz C.O., Morris P.E. (2012). Effect size estimate: current use, calculations and interpretation. Journal of Experimental Psychology: General, 141(1), 2-18. doi:
10.1037/a0024338.
96. Fritz, T., Caidahl, K., Krook, A., Lundström, P., Mashili, F., Osler, M. i wsp. (2013).
Effects of Nordic walking on cardiovascular risk factors in overweight individuals with type 2 diabetes, impaired or normal glucose tolerance. Diabetes Metab Res Rev, 29(1), 25-32. doi: 10.1002/dmrr.2321.
97. Fujita, K., Nishizawa, H., Funahashi, T., Shimomura, I., Shimabukuro, M. (2006).
Systemic Oxidative Stress is Associated With Visceral Fat Accumulation and the Metabolic Syndrome. Circ J, 70, 1437-1442.
98. Fukushima, Y., Kurose, S., Shinno, H., Thi Thu, H.C., Takao, N., Tsutsumi, H.
i wsp. (2016). Effects of Body Weight Reduction on Serum Irisin and Metabolic Parameters in Obese Subjects. Diabetes Metab J, 40(5), 386–395.
doi:10.4093/dmj.2016.40.5.386.
99. Gębicka, L., Didik, J. (2010). Nadtlenoazotyn jako czynnik wywołujący stres oksydacyjny. Postępy Biochemii, 56(2), 103-106.
100. Giannopoulou, I., Fernhall, B., Carhart, R., Weinstock, R.S., Baynard, T., Figueroa, A.
i wsp. (2005). Effects of diet and/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes. Metabolism, 54, 866-875. doi: 10.1016/j.metabol.2005.01.033.
101. Gogga, P., Karbowska, J., Meissner, W., Kochan, Z. (2011). Rola leptyny w regulacji metabolizmu lipidów i węglowodanów. Postępy Hig. Med. Dośw., 65, 255-262.
102. Gomez-Huelgas, R. Ruiz-Nava, J., Santamaria-Fernandez, S., Vargas-Candela, A., Alarcon-Martin, A.V., Tinahones, F.J. I wsp. (2019). Impact of intensive life style modyfication on levels of adipokines and inflammatory biomarkers in metabolically health obese women. Mediators Inflamm, 2019: 4165260. doi:
10.1155/2019/4165260.
103. Goncavles, J.P., Oliveira, A., Severo, M., Santos, A.C., Lopez, C. (2012). Cross-sectional and longitudinal associations betwen serum uric acid and metabolic syndrome. Endocrine, 41, 450-457. doi: 10.1007/s12020-012-9629-8.
104. Gonzalez-Carter, D., Goode, A.E., Fiammengo, R., Dunlop, I.E., Dexter, D.T., Porter, A.E. (2016). Inhibition of Leptin-ObR interaction does not prevent leptin translocation across a human blood-brain barrier model. J Neuroendocrinol., 28(6).
doi: 10.1111/jne.12392.
105. Graf, C., Ferrari, N. (2019). Metabolic Health-The Role of Adipo-Myokines. Int. J.
Mol. Sci., 20(24), 6159. doi:10.3390/ijms20246159.
106. Grundy, S.M. (2012). Pre-diabetes, metabolic syndrome and cardiovascular risk. J.
Am. Coll. Cardiol., 59(7), 635-643. doi: 10.1016/j.jacc.2011.08.080.
107. Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H., Franklin, B.A. i wsp. (2005). Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112, 2735– 2752.
108. Gruzdeva, O., Borodkina, D., Uchasova, E., Dyleva, Y., Barbarash, O. (2019).
Leptin resistance: underlying mechanisms and diagnosis. Diabetes Metab Syndr Obes, 12, 191-198. doi: 10.2147/DMSO.S182406.
109. Gul, A., Rahman, M.A. (2008). Antioxidant status in diabetic and non-diabetic senile patients, with cataract or cardiovascular complications. Saudi Med J, 29, 2, 179-184.
110. Hagner-Derengowska, M., Kaluzny, K., Hagner, W., Kochanski, B., Plaskiewicz, A., Borkowska, A. i wsp. (2015). The influence of a ten-week Nordic walking postmenopausal women in an experimental, nonrandomized, open-label, prospective controlled trial. Menopause, 22(11), 1215-1223.
doi:10.1097/GME.0000000000000446.
112. Haider, D.G., Pleiner, J., Francesconi, M., Wiesinger, G.F., Müller, M., Wolzt, M.
(2006). Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes. J Clin Endocrinol Metab, 91(11), 4702-4704. doi: 10.1210/jc.2006-1013.
113. Halliwell, B. (2006). Oxidative stress and neurodegeneration: where are we now?
J. Neurochem., 97, 1634-1658.
114. Hama, S.G., Ismaeel, A.T., Hussain, S.D. (2017). Oxidative stress in relation to two different pathologies in metabolic syndrome patients. Zanco J. Med. Sci., 21(3), 1829-1839.
115. Harrison, M. (1985). Effects of thermal stress and exercise on blood volume in humans. Physiol. Rev. 65, 149-209. doi: 10.1152/physrev.1985.65.1.149.
116. Harrison, M.H., Graveney, M.J., Cochrane, L.A. (1982). Some sources of error in the calculation of relative change in plasma volume. Eur J Appl Physiol. 50(1), 13-21.
117. Hartvigsen, J., Morso, L., Bendix, T., Manniche, C. (2010). Supervised and non supervised Nordic Walking in the treatment of chronic low back pain: a single blind randomized clinical trial. Muscoloskeletal Disord, 11, 30-39.
118. Hartwich, J., Zdziencka, A., Maziarz, B. (2010). Wartości podstawowych wyników badań w diagnostyce laboratoryjnej. W: Dembińska-Kieć, A., Naskalski, J. W. Diagnostyka laboratoryjna z elementami biochemii klinicznej. Wyd. III.
Elsevier Urban & Partner, Wrocław, Strony 1036-1056.
119. Hayashino, Y., Jackson, J.L., Hirata, T., Fukumori, N., Nakamura, F., Fukuhara, S.
i wsp. (2014). Effects of exercise on C-reactive protein, inflammatory cytokine and adipokine in patients with type 2 diabetes: A meta-analysis of randomized controlled trials. Metabolism., 63, 431-440. doi: 10.1016/j.metabol.2013.08.018.
120. Heilbronn, L.K., Rood, J., Janderova, L., Albu, J.B., Kelley, D.E., Ravussin, E.
i wsp. (2004). Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab, 89, 1844-1848.
121. Hikita, M., Ohno, I., Mori, Y., Ichida, K., Yokose, T., Hosoya, T. (2007). Relationship between hyperuricemia and body fat distribution. Intern. Med., 46, 1353-1358.
122. Hodur M. (2012). Wpływ różnych form aktywności fizycznej na składowe zespołu metabolicznego – przegląd piśmiennictwa. Medicina Sportiva Practica, 13(4), 57-60.
123. Holcomb, I.N., Kabakoff, R.C., Chan, B., Baker, T.W., Gurney, A., Henzel, W.i wsp. (2000). FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J., 19, 4046-4055.
124. Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y.
i wsp. (2000). Plasma concentration of a novel, adipose specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol., 20(6), 1595-1599. doi: 10.1161/01.atv.20.6.1595.
125. Hudson, D. (2014). The effect of walking with poles on the distribution of plantar pressures in normal subjects. PM R., 6(2), 146-151. doi: 10.1016/j.pmrj.2013.09.002.
126. Huh, J., Panagiotou, G., Mougios, V., Brinkoetter, M., Vamvini, M. T., Schneider, B.E. i wsp. (2012). FNDC5 and irisin in humans. I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism, 61(12), 1725-1738. doi: 10.1016/j.metabol.2012.09.002.
127. Huh, J., Panagiotou, G., Mougios, V., Brinkoetter, M., Vamvini, M. T., Schneider, B.E. i wsp. (2012). FNDC5 and irisin in humans. I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism: clinical and experimental, 61(12), 1725-1738. doi: 10.1016/j.metabol.2012.09.002.
128. Hukshorn C.J., Saris W.H.: Leptin and energy expenditure. (2014). Curr. Opin.
Clin. Nutr. Metab. Care, 7(6), 629-633.
129. Hulens, M., Vansant, G., Lysens, R., Claessens, A. L., Muls, E. (2001). Exercise capacity in lean versus obese women. Scand J Med Sci Sports, 11(5), 305-309.
doi: 10.1034/j.1600-0838.2001.110509.x.
130. Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M. (2001).
Cardiovascular morbidity and mortality associated with the metabolic syndrome.
Diabetes Care, 24, 683-689.
131. Izadi, M., Goodarzi, M.T., Khorshidi, D., Doaly, H., Samarikhalaj, H. (2012).
Relationship of serum adiponectin and beta-cell function in obese males with type 2 diabetes. Asian J Pharm Biol Res, 2, 40-44.
132. Jamurtas, A.Z., Theocharis, V., Koukoulis, G., Stakias, N., Fatouros, I.G., Kouretas, D. i wsp. (2006). The effects of acute exercise on serum adiponectin and resistin levels and their relation to insulin sensitivity in overweight males. Eur. J.
Appl. Physiol. 97, 122-126. doi: 10.1007/s00421-006-0169-x.
133. Janowska, J., Zahorska-Markiewicz, B., Olszanecka-Glinianowicz, M. (2006).
Relationship between serum resistin concentration and proinflammatory cytokines in obese women with impaired and normal glucose tolerance. Metabolism, 55, 1495-1499.
134. Jones, T., Basilio, J., Brophy, P., McCammon, M., Hickner, R. (2009). Longterm exercise training in overweight adolescents improves plasma peptide YY and resistin. Obesity, 17, 1189-1195. doi: 10.1016/j.dcn.2011.01.002.
135. Jorge, M.L., de Oliveira, V.N., Resende, N.M., Paraiso, L.F., Calixto, A., Diniz, A.L. i wsp. (2011). The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus. Metabolism, 60(9), 1244-1252.
doi: 10.1016/j.metabol.2011.01.006.
136. Jung, T.W., Kim, H.C., Kim, H.U., Park, T., Park, J., Kim, U. i wsp. (2019).
Asprosin attenuates insulin signaling pathway through PKCdelta-activated ER stress and inflammation in skeletal muscle. J Cell Physiol, 234, 20888-20899.
doi: 10.1002/jcp.28694.
137. Kadoglou, N., Perrea, D., Iliadis, F., Angelopoulou, N., Liapis, C., Alevizos, M.
(2007). Exercise reduces resistin and inflammatory cytokines in patients with type 2 diabetes. Diabetes Care, 30, 719-721. doi: 10.2337/dc06-1149.
138. Kanbay, M., Jensen, T., Solak, Y., Le, M., Roncal-Jimenez, C., Rivard, C. i wsp.
(2016). Uric acid in metabolic syndrome: From an innocent bystander to a central player. Eur J Inter Med, 29, 3-8. doi: 10.1016/j.ejim.2015.11.026.
139. Kantorowicz M., Augustyn G., Więcek M. (2015). Oxidative stres and training.
Antropomotoryka. JKES, 72(25), 69-78. doi: 10.5604/17310652.1210194.
140. Kantorowicz M., Więcek M. (2016). Poziom świadomości żywieniowej mężczyzn na temat źródeł antyoksydantów i znaczenia równowagi prooksydacyjno-antyoksydacyjnej organizmu dla zdrowia. Państwo i Społeczeństwo, 4, 27-36.
141. Kao, H.-H., Hsu, H.-S., Wu T.-H., Chiang H.-F., Huang H-Y., Wang H.-J. i wsp.
(2021). Effects of a single bout of short-duration high-intensity and long-duration low-intensity exercise on insulin resistance and adiponectin/leptin ratio. Obes Res Clin Pract, 15(1), 58-63. doi: 10.1016/j.orcp.2020.09.007.
142. Kargarfard, M., Shariat, A., Shaw, I., Haddadi, P., Shaw, B.S. (2017). Effects of Resistance and Aerobic Exercise Training or Education Associated with a Dietetic Program on Visfatin Concentrations and Body Composition in Overweight and Obese Women. Asian J Sports Med., 8(4), 57690. doi: 10.5812/asjsm.57690.
143. Karolkiewicz, J., Michalak, E., Pospieszna, B., Deskur-Smielecka, E., Nowak, A., Pilaczyńska-Szcześniak, Ł. (2009). Response of oxidative stress markers and antioxidant parameters to an 8-week aerobic physical activity program in healthy, postmenopausal women. Arch Gerontol Geriatr, 49(1), 67-71.
143. Karolkiewicz, J., Michalak, E., Pospieszna, B., Deskur-Smielecka, E., Nowak, A., Pilaczyńska-Szcześniak, Ł. (2009). Response of oxidative stress markers and antioxidant parameters to an 8-week aerobic physical activity program in healthy, postmenopausal women. Arch Gerontol Geriatr, 49(1), 67-71.